Dr. Rajendra Kumar Manam, MD

Dr. Manam practices at Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Manam's NPI, 1134237050, was assigned on August 29, 2006. Dr. Manam holds Michigan license 4301067586.

Dr. Manam's primary practice is Henry Ford St. John Hospital, at 22101 Moross Rd, Detroit, MI 48236 in Wayne County. The practice phone is (313) 343-4000.

Dr. Manam's primary practice is Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Manam is also affiliated with Henry Ford Providence Southfield Hospital. The medical group on file is Henry Ford St. John Hospital. Dmand AI also links Dr. Manam to 1 more group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manam practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Manam's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Manam is licensed in Michigan.

CMS data shows 1,102 Medicare services from Dr. Manam across 10 procedure codes in 2024, for 387 Medicare patients. Medicare paid $83,062 for them.

CMS counts 387 Medicare patients who saw Dr. Manam in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manam's median patient age at 72, with 60% women.

In 2024, Dr. Manam wrote 1,179 Medicare Part D claims for 279 patients. 72% of them were for generic drugs. CMS names the drug for 1,009 of them, across 18 drugs with 11 or more claims each, at $4,680,818 in total drug cost. In 2023, CMS named 1,136 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Manam for performance year 2024, reported through an alternative payment model (APM). Dr. Manam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manam as offering telehealth.

Dmand AI links 2 papers to Dr. Manam in 2023. 2023 was the busiest year, with 2. Dr. Manam's most frequent co-authors are Ammar Moin Ahmed, MD and Elton Yichao Li, MD.

Dmand AI links Dr. Manam to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 206 general payments to Dr. Manam from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $358.